Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02664636
Other study ID # LOCAL/2015/JF-02
Secondary ID 2015-A01624-45
Status Completed
Phase N/A
First received January 19, 2016
Last updated August 25, 2016
Start date February 2016
Est. completion date August 2016

Study information

Verified date August 2016
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santéFrance: Committee for the Protection of Personnes
Study type Interventional

Clinical Trial Summary

The main objective is to develop models for the cortical reorganization of motor areas and inter-hemispheric equilibrium in the early phase of post stroke recovery evaluated by the fNIRS technique from day 0 to day 60 (day 0 being the day of inclusion in the study) and to correlate the latter with the early phases of motor recovery over the same period, as measured by the test Fugl-Meyer.


Description:

The secondary objectives of this study are:

A. To evaluate changes in functional outcomes (Box and Blocks Test and NineHolePeg Test from Day 0 to Day 60.

B- To evaluate changes in autonomy (Barthel Index) from Day 0 to Day 60.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria:

- The patient must have given his/her informed and signed consent

- The patient must be insured or beneficiary of a health insurance plan

- The patient has had a first ischemic or haemorrhagic supra-tentorial stroke within the 2 to 4 weeks preceding inclusion

Exclusion Criteria:

- The patient is participating in another study

- The patient is in an exclusion period determined by a previous study

- The patient is under judicial protection, under tutorship or curatorship

- The patient refuses to sign the consent

- It is impossible to correctly inform the patient

- The patient is pregnant, parturient, or breastfeeding

- The patient presents with a severe cognitive disorder

- The patient has severe aphasia with a Boston Diagnostic Aphasia Examination (BDAE) scale score strictly less than 2

- The patient has heminegligence with a bells test > 6 on the left.

- The patient presents with limited amplitude in the paretic upper limb (shoulder abduction <60°, elbow flexion > 30° or dorsal wrist flexion <20°).

- Imbalanced/uncontrolled epilepsy

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Physiotherapy
Physiotherapy regimen (days 0 to 60): orthopedic maintenance, work on trunk balance, sensorimotor techniques for restoration of motor skills, exercises for standing balance and walking. Sessions last 30 to 60 minutes depending on the fatigue of the subject and the level of recovery. They occur as daily sessions during the first two weeks and then two sessions / day. This is part of routine care.
Occupational therapy
Occupational Therapy (days 0 to 60): Orthopaedic maintenance, exercises for sitting and standing balance, sensorimotor techniques for the restoration of motor skills, grip exercises. Sessions last 30 to 60 minutes depending on the fatigue of the subject and the level of recovery. 1 session is performed per day. This is part of routine care.
Functional near-infrared spectroscopy
During the therapy protocol, cortical activation measures using the fNIRS method will be conducted every 15 days (at Day0, Day 15, Day 30, Day 45 and Day 60 for 5 sessions in total) at the technical platform of the Grau du Roi physical therapy centre, during the completion of a standardized motor task (maintaining a level of force) using the healthy upper limb and the paretic upper limb.

Locations

Country Name City State
France CHRU de Nîmes - Hôpital Universitaire de Réadaptation du Grau du Roi Le Grau du Roi
France CHRU de Montpellier - Hôpital Lapeyronie Montpellier

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Near-infrared spectroscopy signal analysis: the average amplitude of cortical activation Day 0 No
Primary Near-infrared spectroscopy signal analysis: the average amplitude of cortical activation Day 15 No
Primary Near-infrared spectroscopy signal analysis: the average amplitude of cortical activation Day 30 No
Primary Near-infrared spectroscopy signal analysis: the average amplitude of cortical activation Day 45 No
Primary Near-infrared spectroscopy signal analysis: the average amplitude of cortical activation Day 60 No
Primary Near-infrared spectroscopy signal analysis: the amplitude peak Day 0 No
Primary Near-infrared spectroscopy signal analysis: the amplitude peak Day 15 No
Primary Near-infrared spectroscopy signal analysis: the amplitude peak Day 30 No
Primary Near-infrared spectroscopy signal analysis: the amplitude peak Day 45 No
Primary Near-infrared spectroscopy signal analysis: the amplitude peak Day 60 No
Primary Near-infrared spectroscopy signal analysis: the time required to reach the peak Day 0 No
Primary Near-infrared spectroscopy signal analysis: the time required to reach the peak Day 15 No
Primary Near-infrared spectroscopy signal analysis: the time required to reach the peak Day 30 No
Primary Near-infrared spectroscopy signal analysis: the time required to reach the peak Day 45 No
Primary Near-infrared spectroscopy signal analysis: the time required to reach the peak Day 60 No
Primary Near-infrared spectroscopy signal analysis: the laterality index Day 0 No
Primary Near-infrared spectroscopy signal analysis: the laterality index Day 15 No
Primary Near-infrared spectroscopy signal analysis: the laterality index Day 30 No
Primary Near-infrared spectroscopy signal analysis: the laterality index Day 45 No
Primary Near-infrared spectroscopy signal analysis: the laterality index Day 60 No
Primary Voluntary force: the target error which measures the difference between the average of the force developed by the arm and target strength Voluntary force refers to the force applied during motricity tasks. Day 0 No
Primary Voluntary force: the target error which measures the difference between the average of the force developed by the arm and target strength Voluntary force refers to the force applied during motricity tasks. Day 15 No
Primary Voluntary force: the target error which measures the difference between the average of the force developed by the arm and target strength Voluntary force refers to the force applied during motricity tasks. Day 30 No
Primary Voluntary force: the target error which measures the difference between the average of the force developed by the arm and target strength Voluntary force refers to the force applied during motricity tasks. Day 45 No
Primary Voluntary force: the target error which measures the difference between the average of the force developed by the arm and target strength Voluntary force refers to the force applied during motricity tasks. Day 60 No
Primary Voluntary force: average Voluntary force refers to the force applied during motricity tasks. "Average" refers to the sum of measures weighted by the number of measures. Day 0 No
Primary Voluntary force: average Voluntary force refers to the force applied during motricity tasks. "Average" refers to the sum of measures weighted by the number of measures. Day 15 No
Primary Voluntary force: average Voluntary force refers to the force applied during motricity tasks. "Average" refers to the sum of measures weighted by the number of measures. Day 30 No
Primary Voluntary force: average Voluntary force refers to the force applied during motricity tasks. "Average" refers to the sum of measures weighted by the number of measures. Day 45 No
Primary Voluntary force: average Voluntary force refers to the force applied during motricity tasks. "Average" refers to the sum of measures weighted by the number of measures. Day 60 No
Primary Voluntary force: coefficient of variation Voluntary force refers to the force applied during motricity tasks. Day 0 No
Primary Voluntary force: coefficient of variation Voluntary force refers to the force applied during motricity tasks. Day 15 No
Primary Voluntary force: coefficient of variation Voluntary force refers to the force applied during motricity tasks. Day 30 No
Primary Voluntary force: coefficient of variation Voluntary force refers to the force applied during motricity tasks. Day 45 No
Primary Voluntary force: coefficient of variation Voluntary force refers to the force applied during motricity tasks. Day 60 No
Primary Fugl-Meyer motricity score The Fugl-Meyer motricity score includes evaluations of tone, strength and motor skills. Day 0 No
Primary Fugl-Meyer motricity score The Fugl-Meyer motricity score includes evaluations of tone, strength and motor skills. Day 15 No
Primary Fugl-Meyer motricity score The Fugl-Meyer motricity score includes evaluations of tone, strength and motor skills. Day 30 No
Primary Fugl-Meyer motricity score The Fugl-Meyer motricity score includes evaluations of tone, strength and motor skills. Day 45 No
Primary Fugl-Meyer motricity score The Fugl-Meyer motricity score includes evaluations of tone, strength and motor skills. Day 60 No
Secondary The Box and Block test: The score is the number of blocks transferred in one minute. Day 0 No
Secondary The Box and Block test: The score is the number of blocks transferred in one minute. Day 60 No
Secondary The Nine Hole Peg Test: The score is the total time to complete the task. Day 0 No
Secondary The Nine Hole Peg Test: The score is the total time to complete the task. Day 60 No
Secondary The Barthell test for autonomy Day 0 No
Secondary The Barthell test for autonomy Day 60 No
See also
  Status Clinical Trial Phase
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Recruiting NCT03869138 - Alternative Therapies for Improving Physical Function in Individuals With Stroke N/A
Completed NCT04034069 - Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial N/A
Completed NCT04101695 - Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects N/A
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Completed NCT00391378 - Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS) N/A
Recruiting NCT06204744 - Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial N/A
Active, not recruiting NCT06043167 - Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
Active, not recruiting NCT04535479 - Dry Needling for Spasticity in Stroke N/A
Completed NCT03985761 - Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke N/A
Recruiting NCT00859885 - International PFO Consortium N/A
Recruiting NCT06034119 - Effects of Voluntary Adjustments During Walking in Participants Post-stroke N/A
Completed NCT03622411 - Tablet-based Aphasia Therapy in the Chronic Phase N/A
Completed NCT01662960 - Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke N/A
Recruiting NCT05854485 - Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke N/A
Active, not recruiting NCT05520528 - Impact of Group Participation on Adults With Aphasia N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Completed NCT05805748 - Serious Game Therapy in Neglect Patients N/A
Recruiting NCT05993221 - Deconstructing Post Stroke Hemiparesis